MedTrace Logo

Bleeding in Patients Undergoing CABG (Coronary Artery Bypass Graft) During Dual Antiplatelet Therapy

NCT02030548 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2019-06-06

No results posted yet for this study

Summary

The aim of the study is to evaluate surgery-related bleeding and mortality in patients needing acute coronary artery bypass grafting with or without valve replacement during dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker (Clopidogrel, Prasugrel, Ticagrelor)

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Elisabeth Mahla, MD · Dept. of Anesthesiology and Intensive Care Medicine, MUG

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02030548 on ClinicalTrials.gov